Recently, I sent you guidance from the CDC about using Enhanced Barrier Precautions for patients with drug resistant organisms, wounds, and indwelling catheters.  
This is an update to CDC guidance, and to my knowledge is NOT a CMS requirement.  As such, there is no regulatory requirement to implement this guidance (yet).  
So, I'd like to rescind any formal recommendation that I may have made and instead ask you to look at the information and consider if it may fit into your infection control process.  
Certainly, a closer attention to wounds in those with MDROs (multidrug resistant organisms) makes sense and using EBP for these patients would not be a bad idea. 
Below is a link to an AHCA article on the topic and other information in case you are interested.  I'll keep an eye on the topic and let you know if things change. 
 DS

DCS Internal Medicine, LLC
Dr. David Shepherd DO, MBA, MS, CMD
Internal Medicine Physician, Medical Informaticist, Medical Director
3472 Research Parkway, Suite 104-412
Colorado Springs, CO 80920
Office Phone: 719-286-9330
Office fax: 844-704-5752